September 24, 2014 / 1:28 PM / 4 years ago

Salix contacts Actavis over potential sale-source

NEW YORK, Sept 24 (Reuters) - Salix Pharmaceuticals Ltd has had contact with Actavis Plc about a potential sale to the larger drugmaker, as it continues discussions with Allergan Inc about selling itself, according to a person familiar with the matter.

Allergan has revived discussions to buy Salix in recent weeks after on-and-off talks for nearly a year, as it tries to fend off a hostile offer from Valeant Pharmaceuticals Inc , Reuters reported earlier this week.

CNBC reported earlier Wednesday that Salix was in early-stage discussions with Actavis.

Representatives for Salix and Actavis could not be immediately reached for comment. (Reporting by Olivia Oran in New York; Editing by Bernadette Baum)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below